Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.
01 1Phyton Biotech LLC
02 1Hubei Haosun Pharmaceutical Co., Ltd.
03 1Indena SpA
04 1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
05 2MSN Laboratories Private Limited
06 1Qilu Pharmaceutical Co. Ltd.
07 1Qilu Pharmaceutical Co., Ltd.
08 4ScinoPharm Taiwan Ltd.
09 1Sicor de Mexico S.A. de C.V
10 1Yung Shin Pharmaceutical Ind. Co., Ltd.
01 6Docetaxel
02 5Docetaxel Anhydrous
03 1Docetaxel Trihydrate
04 1Docetaxel trihydrate
05 1docetaxel trihydrate
01 1Canada
02 5China
03 2India
04 1Italy
05 1Mexico
06 4Taiwan
Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.
NDC Package Code : 51446-0220
Start Marketing Date : 2012-11-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14778-1212
Start Marketing Date : 2011-10-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17359-9100
Start Marketing Date : 2020-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57884-0014
Start Marketing Date : 2010-09-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0008
Start Marketing Date : 2011-10-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0018
Start Marketing Date : 2013-07-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65129-1141
Start Marketing Date : 2001-08-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65129-1141
Start Marketing Date : 2001-08-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63592-0360
Start Marketing Date : 2018-10-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63126-901
Start Marketing Date : 2012-12-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Docetaxel manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Docetaxel, including repackagers and relabelers. The FDA regulates Docetaxel manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Docetaxel API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Docetaxel manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Docetaxel supplier is an individual or a company that provides Docetaxel active pharmaceutical ingredient (API) or Docetaxel finished formulations upon request. The Docetaxel suppliers may include Docetaxel API manufacturers, exporters, distributors and traders.
click here to find a list of Docetaxel suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Docetaxel as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Docetaxel API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Docetaxel as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Docetaxel and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Docetaxel NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Docetaxel suppliers with NDC on PharmaCompass.
We have 9 companies offering Docetaxel
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
